EUVIMEDEUVIMED entdecken
Crossref

Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey

Arzu Aras iD, Ali Avanaz iD, Nurel Inan Aydemir iD, Ece Kayaalp iD, Nazan Ulgen Tekerek iD, Abdullah Kisaoglu iD, Ismail Demiryilmaz iD, Erdogan Soyucen iD, Oguz Dursun iD, Aygen Yilmaz iD, Reha Artan iD, Bulent Aydinli iD

Pediatric Transplantation · 2023-05 · 27 (3)

DOI: 10.1111/petr.14464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2023-01. Verfasst von Arzu Aras und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Akdeniz University School of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Maple Syrup Urine Disease, Liver Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Maple syrup urine disease (MSUD) is an autosomal recessive inherited disorder. Despite the advances in medical nutrition therapies, classical phenotype causes severe neurological disorders and sudden death. It is known that MSUD patients do not experience metabolic attacks despite their free diet after liver transplantation (LT). This study aims to reveal the long‐term results, development, mental, motor, intellectual and nutritional status of MSUD patients who underwent LT.

Methods

The data of 12 patients who underwent deceased donor (5 recipients) and living donor liver transplantation (7 recipients) were retrospectively analyzed. The age, genotype, psychometric and mental status, development, BCAA values, type of LT, donor‐recipient proximity, complications, and survival were assessed.

Results

There were 4 (33%) girls and 8 (67%) boys. The mean current age was 9.33 ± 4.58 years. The mean follow‐up time was 3 ± 2.5 years. The repeated measures of leucine and isoleucine values revealed that there were no significant differences from the pre‐LT to post‐LT 1‐year. The protein‐restricted nutrition was switched to a free diet when oral intake was opened after LT. None of the recipients experienced metabolic attacks after the living donor or deceased donor LT. The 1‐, 3‐, and 5‐year survival rate of the patients is 83.3%. There was no significant difference in survival between living and deceased donor liver transplantation.

Conclusions

Liver transplantation is a treatment option for MSUD in proper conditions to save the patient life, increase the quality of life, and provide essential amino acids with free diet intake for growth and development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Maple Syrup Urine DiseaseLiver TransplantationHumansLiving DonorsRetrospective StudiesTurkeyQuality of Life

Stichwörter der Autor:innen

branched-chain ketoacidurialiver transplantliving donorstransplant recipients

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology, Akdeniz University School of Medicine, Antalya, Turkey.
  • Department of Organ Transplantation, Akdeniz University School of Medicine, Antalya, Turkey.
  • Department of Pediatric Nutrition and Metabolism, Akdeniz University School of Medicine, Antalya, Turkey.
  • Department of Pediatric Intensive Care, Akdeniz University School of Medicine, Antalya, Turkey.

ORCID-Profile: Arzu Aras, Ali Avanaz, Nurel Inan Aydemir, Ece Kayaalp, Nazan Ulgen Tekerek, Abdullah Kisaoglu, Ismail Demiryilmaz, Erdogan Soyucen, Oguz Dursun, Aygen Yilmaz, Reha Artan, Bulent Aydinli

Zitieren

APA

Aras, A., Avanaz, A., Inan Aydemir, N., Kayaalp, E., Ulgen Tekerek, N., Kisaoglu, A., Demiryilmaz, I., Soyucen, E., Dursun, O., Yilmaz, A., Artan, R., & Aydinli, B. (2023). Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey. Pediatric Transplantation, 27(3). https://doi.org/10.1111/petr.14464

Vancouver

Aras A, Avanaz A, Inan Aydemir N, Kayaalp E, Ulgen Tekerek N, Kisaoglu A, et al. Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey. Pediatric Transplantation. 2023;27(3). doi:10.1111/petr.14464

BibTeX
@article{Aras2023,
  author = {Aras, Arzu and Avanaz, Ali and Inan Aydemir, Nurel and Kayaalp, Ece and Ulgen Tekerek, Nazan and Kisaoglu, Abdullah and Demiryilmaz, Ismail and Soyucen, Erdogan and Dursun, Oguz and Yilmaz, Aygen and Artan, Reha and Aydinli, Bulent},
  title = {Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey},
  journal = {Pediatric Transplantation},
  year = {2023},
  volume = {27},
  number = {3},
  doi = {10.1111/petr.14464}
}
Kostenlos starten →